Pure Global AI
NCT06393634Enrolling by invitation

Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration

Comparing Direct and Indirect Detection Methods Following Multiple Routes of Testosterone administration-an Anti-doping Perspective
Sports Medicine Research and Testing LaboratoryPhase 1ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Healthy
Drug/Device/Intervention
Testosterone injection
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Sports Medicine Research and Testing Laboratory
Location
South Jordan, United States of America
Timeline & enrollment
Phase
Phase 1
Start date
May 08, 2024
End date
Aug 01, 2024
Enrollment
15 participants
Primary outcome

Detection windows of testosterone administered via injection, oral and skin cream.,Changes in serum concentration of testosterone,Changes in serum concentration of androstenedione,Changes in serum concentration of luteinizing hormone

Summary

Testosterone abuse is extremely prevalent in athletes globally and especially in the United
 States professional sporting leagues

ICD-10 classifications
ObesitySeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulHealthy person accompanying sick personLifestyle-related conditionMalnutrition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06393634
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06393634 through Pure Global AI's free database. This Phase 1 trial is sponsored by Sports Medicine Research and Testing Laboratory and is currently Enrolling by invitation. The study focuses on Healthy. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.